fbpx
December 9, 2021

CDC, FDA Sign Off on Pfizer Boosters for 16- and 17-Year-Olds CDC, FDA Sign Off on Pfizer Boosters for 16- and 17-Year-Olds

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) authorized booster doses of Pfizer’s […]
December 9, 2021

AHA, AMA Sue Federal Government Over Surprise Billing Law AHA, AMA Sue Federal Government Over Surprise Billing Law

Hospital and physician groups on Thursday announced their plan to sue the federal government over its plan for addressing disputes about surprise medical bills, which tilts […]
December 6, 2021

Class I Recall of Percutaneous Thrombolytic Device Class I Recall of Percutaneous Thrombolytic Device

Arrow International Inc, a subsidiary of Teleflex, has recalled a total of 3241 Arrow-Trerotola over-the-wire 7FR percutaneous thrombolytic device (PTD) kits because of the risk of […]
December 3, 2021

FDA Approves Rituximab for Multiple Pediatric Cancers FDA Approves Rituximab for Multiple Pediatric Cancers

The US Food and Drug Administration yesterday approved rituximab (Rituxan) in combination with chemotherapy for pediatric patients (age 6 months to <18 years) with previously untreated, advanced stage, […]
December 1, 2021

FDA Approves Time-Saving Combo for R/r Multiple Myeloma FDA Approves Time-Saving Combo for R/r Multiple Myeloma

The US Food and Drug Administration (FDA) this week approved daratumumab + hyaluronidase-fihj (Darzalex Faspro) and carfilzomib (Kyprolis) plus dexamethasone (Kd) for patients with relapsed or […]
November 30, 2021

After Doc Uproar, NCCN Reverses Prostate Cancer Guidance After Doc Uproar, NCCN Reverses Prostate Cancer Guidance

After making a controversial change in September to a long-standing recommendation about the use of active surveillance in men with prostate cancer, the National Comprehensive Cancer […]
November 29, 2021

FDA Approves Imaging Drug for Detecting Ovarian Cancer Lesions FDA Approves Imaging Drug for Detecting Ovarian Cancer Lesions

The US Food and Drug Administration has approved pafolacianine (Cytalux), an imaging drug indicated for use in adult patients with ovarian cancer undergoing surgery. The new […]
November 26, 2021

New COVID Variant of Concern Drives US Travel Bans New COVID Variant of Concern Drives US Travel Bans

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The World Health Organization (WHO) on Friday classified a new COVID-19 variant […]
November 24, 2021

FDA Approves First Drug for Treatment of Resistant CMV FDA Approves First Drug for Treatment of Resistant CMV

The US Food and Drug Administration (FDA) has approved the first treatment for post-transplant cytomegalovirus (CMV) that is resistant to other drugs. The treatment, maribavir (Livtencity), […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0